You have read all your free articles, to continue reading subscribe to read the rest of this content.
Norwegian company Oncoinvent has announced the closing of a 210 MNOK (approx. 25 MUSD) private placement of ordinary shares. Large privately owned investment companies joining the company as new investors include Geveran Trading Co. Ltd., Canica AS, CGS Holding AS, Helene Sundt AS and Must InvestAlready a subscriber Login You…
The US Food and Drug Administration (FDA) has approved the self-administration of Fasenra (benralizumab) in a pre-filled, single-use auto-injector (the Fasenra Pen). The approval is supported by data from the Phase III GRECO trial and the Phase I AMES trial. The safety and tolerability of FasenrAlready a subscriber Login You have…
Earlier this summer Immunicum announced a corporate rebranding and name change to Mendus and most recently the company reported financing commitments totaling up to 250 million SEK. NLS asked Erik Manting, CEO, about what lies ahead. What opportunities do you have on the market for cancer immunotAlready a subscriber Login…
AstraZeneca has agreed the sale and licence of the commercial rights to Seroquel (quetiapine fumarate immediate release) and Seroquel XR (quetiapine fumarate extended release) in Europe and Russia to Cheplapharm. Seroquel and Seroquel XR, used primarily to treat schizophrenia and bipolar disorderAlready a subscriber Login You have read all your…
